BioSpace News Archive

Drug Development

GenSight Biologics Provides an Update on the Clinical and Regulatory Pathways for GS010

Additional Week 72 (18-month) data point for REVERSE expected in early Q4 2018

September 13, 2018
·
7 min read
Policy

Tilray® Exports Bulk Supply of Medical Cannabis Flower to Germany

Tilray becomes first and only company with both flower and oil medical cannabis products available in the German market

September 13, 2018
·
2 min read
BioForest

Greenstreet Growers Inc. Launches Plant-Based Air Purifier, brēth, in New Kickstarter Campaign

Active Technology Cleans Over 70 Percent of Harmful Toxins and Pollutants in Homes and Offices with the Equivalent of Almost 200 Houseplants

September 13, 2018
·
4 min read
Deals

Viper Equity Partners of Palm Beach Makes Aggressive Move Into Dental

David Branch a Principal at Viper explained their focus to become the key facilitator of deals in bringing the dental community and DSO’s togethe

September 13, 2018
·
2 min read
Business

Targovax Strengthens Management Team With the Appointment of Torbjørn Furuseth as CFO; Erik Digman Wiklund to become CBO

Targovax ASA announces the appointment of Dr. Torbjørn Furuseth as CFO, effective 24 September 2018.

September 13, 2018
·
2 min read
Global Healthcare IT Market 2018-2022 | Emergence of AI-enabled Emotion Recognition Technologies to Boost Growth | Technavio

The global healthcare IT market is expected to post a CAGR of over 8% during the period 2018-2022, according to the latest market research report by Technavio.

September 13, 2018
·
4 min read
Notice to Attend the Extraordinary General Meeting in IRRAS Ab (publ)

The shareholders in IRRAS AB are hereby given notice to attend the extraordinary general meeting held on Monday, 1 October 2018 at 10:00 a.m. (CEST) at the premises of Setterwalls Advokatbyrå with address Sturegatan 10 in Stockholm, Sweden.

September 13, 2018
·
7 min read
Policy

New U.S. Patents Granted for RegenLab

Mr. Antoine Turzi, inventor, Regen Lab SA and RegenLab USA LLC are delighted to announce that the United States Patent and Trademark Office (USPTO) has issued two new U.S. patents covering its Platelet Rich Plasma (PRP), Bone Marrow Concentrate (BMC) and Hyaluronic Acid (HA) technologies

September 13, 2018
·
1 min read
Deals

Boehringer Ingelheim Acquires All ViraTherapeutics Shares to Develop Next Generation Viral-Based Immuno-Oncology Therapies

Boehringer Ingelheim exercises its option to acquire all shares of oncolytic virus company ViraTherapeutics

September 13, 2018
·
4 min read
Biotech Bay

Blood Cancer Survivor to Throw Out the First Pitch at Sept. 16 Houston Astros Game

Event to Help Boost Multiple Myeloma Awareness and Planning

September 13, 2018
·
3 min read